The Companies That Pulled In Japan's Biggest Tech Checks This Decade
From a payments app that just priced a blockbuster Nasdaq debut to a biomaterials lab spinning lab-grown silk, a handful of Japanese companies have absorbed the lion's share of venture capital flowing into the country over the past ten years.
Japan spent years being described as a country of cautious corporates and slow-moving capital. That reputation is increasingly out of date. Over the last decade a small cluster of startups — spanning payments, HR software, biomaterials and AI — has pulled in the overwhelming majority of the country's venture and growth funding, and several have gone on to become the biggest technology exits Japan has ever produced.
Payments Took the Crown
No company captures the scale of Japan's tech funding boom better than PayPay. Launched in 2018 as a joint venture between SoftBank and Yahoo Japan, the mobile wallet clawed its way to dominance by waiving merchant fees and showering users with cashback promotions. That aggressive playbook worked: by the end of 2025 PayPay counted roughly 72 million registered users in a country of about 123 million people, and QR-code payments had gone from a rounding error to nearly a tenth of all cashless transactions nationwide.
That growth culminated in a Nasdaq listing in March 2026, where PayPay and an affiliated SoftBank fund sold shares to raise close to $880 million, pricing the company at roughly $12.7 billion — comfortably the largest U.S. listing ever completed by a Japanese firm. Shares jumped nearly a fifth on their debut, a signal that investors still see room to grow even in a maturing domestic payments market.
The Rest of the Pack
Behind PayPay sits a more varied group of companies, each pulling capital from a different corner of the investment world. SmartHR, the cloud-based human resources platform founded in 2013, has quietly become one of the country's most durable SaaS successes, raising more than $300 million across nine rounds and hitting a $1.6 billion valuation with backing from KKR, General Atlantic and Sequoia's growth arm. It was reportedly lining up a Tokyo listing before pushing the timeline out to 2027 amid investor caution about how AI might reshape enterprise software.
Spiber has taken a very different route to a similar outcome. The Yamagata-based biotech spent over a decade engineering "Brewed Protein," a lab-fermented alternative to silk and other animal or petroleum-based fibers, before crossing unicorn status in 2021 on a funding round led by the Carlyle Group. Its materials now show up in products from The North Face, Goldwin and Toyota, and the company has since raised further rounds to scale up manufacturing.
On the AI side, Preferred Networks built its valuation the old-fashioned way — through deep partnerships with Japanese industrial giants like Toyota and FANUC rather than mass-market consumer products, applying deep learning to robotics, drug discovery and autonomous driving. Sakana AI took the opposite path, becoming the fastest Japanese startup ever to reach unicorn status after founding in 2023, riding a wave of interest in efficient, smaller AI models and landing backing from major domestic banks and telecoms.
The size of these rounds tells a bigger story than any single company: global investors are finally treating Japanese technology as a growth bet, not just a value play.
What This Means Going Forward
Japan's government has set a target of cultivating 100 unicorns by 2027, a goal that still looks distant with roughly ten confirmed today. But the trajectory matters more than the headline number. Disclosed venture and growth funding into Japanese startups is estimated to have topped $35 billion between 2015 and 2024, with the pace accelerating sharply after 2019 as corporate venture arms, government-backed funds and international investors all increased their participation. PayPay's Nasdaq debut, in particular, may prove to be a turning point — a proof point that Japanese companies can pursue U.S. listings at scale rather than settling for smaller domestic IPOs.
The mix of sectors represented here — payments, HR software, biomaterials and AI — also suggests Japan's funding story isn't cornered in one niche. Investors are placing serious bets across consumer tech, enterprise software and genuinely novel deep tech, which bodes well for the next wave of companies working their way up through seed and Series A rounds today.
- PayPay set the decade's benchmark. Its $12.7 billion Nasdaq valuation and roughly $880 million raise mark the largest U.S. listing by a Japanese company to date.
- Funding is spread across sectors. Fintech, HR SaaS, biomaterials and AI all produced billion-dollar-plus outcomes, not just one hot category.
- Deep tech can still win big in Japan. Spiber's fourteen-year path to unicorn status shows patient capital still has a home here.
- AI funding is bifurcating. Corporate-partnership models (Preferred Networks) and fast-scaling model labs (Sakana AI) are both attracting serious capital.
- The unicorn count is still small but rising. Roughly ten confirmed unicorns exist today against a government target of 100 by 2027, leaving plenty of room for new entrants.
